Discuss a project

Drug Product Scale-Up and CDMO Tech Transfer

Upperton’s process development services support with projects moving from R&D into scale up, working on one site to get teach transfer right first time.

Tech Transfer with Upperton

Reduce risk and protect your processes with confidence

Scaling from early development to GMP shouldn’t introduce risk. Our tech transfer framework ensures your process, materials, analytics, and know‑how move into GMP operations with speed, in as little as 3 months. With our expertise you can stay focused on advancing your program, not managing complexity. 

Tech transfer

Phase-appropriate transfer plans aligned to your CMC strategy

Tech transfer to a new CDMO can expose gaps in documentation, methods, materials, or knowledge that slow your timeline. Our structured approach using Quality by Design (QbD) and Design of Experiments (DoE), identifies and resolves these risks early, ensuring a fast, reliable handover with minimal disruption. 

We provide:

·  Rapid onboarding
· A cross‑functional tech transfer team  
·  Early identification of process gaps to avoid downstream delays  
· Transparent documentation and communication throughout  
·  Repeatable framework scaling from preclinical to commercial


Are you tech transfer ready?

Download our checklist to evaluate whether your process, analytics, and documentation are ready for transfer, and identify risks before they impact your timeline.

Tech Transfer Frequently Asked Questions

Technology transfer is the structured process of transferring product knowledge, manufacturing processes, analytical methods, and quality requirements from one organisation, site, or development stage to another. The goal is to ensure the product can be manufactured consistently, safely, and compliantly at the receiving facility.

A successful technology transfer helps ensure product quality, minimises development risks, reduces delays, and supports a smooth transition from development to clinical or commercial manufacturing. Effective technology transfer is essential for maintaining process performance and regulatory compliance throughout a product's lifecycle.

Technology transfer can occur at several stages, including: Moving from formulation development to GMP manufacturing, transferring a process between manufacturing facilities, scaling up from laboratory to pilot or commercial scale, moving a product from one CDMO to another, introducing a commercial product to a new manufacturing site.

A comprehensive technology transfer package typically includes:

• Manufacturing processes and batch records
• Formulation and process development reports
• Analytical methods and validation data
• Specifications and acceptance criteria
• Stability data
• Equipment requirements
• Regulatory documentation

The timeline depends on the complexity of the product, process maturity, regulatory requirements, and level of existing documentation. Simple transfers may take a few months, while more complex projects involving novel formulations or sterile manufacturing can take significantly longer.

Common challenges include:

• Incomplete or inconsistent documentation
• Process variability
• Differences in equipment or facility capabilities
• Analytical method transfer issues
• Tight project timelines
• Supply chain constraints
• Managing stakeholder communication across multiple teams

Let’s put the confidence in your tech transfer and get your program moving.

Contact our team to successfully relocate your manufacturing with confidence.

Related Services

·        FIH Manufacturing
·        Phase I/II Clinical Supply
·        Process Development

Related Content

·       The Art and Science of Tech Transfer
·       The Role of Technical Transfer in Pharmaceutical Manufacturing.
·       How Technical Transfer and Programme Management Work Together to Deliver Successful Product Development
·       Tech Transfer in Late-Stage Oral Solid Dose Projects: Lessons Learnt and Best Practices from a CDMO Perspective

Download Information Sheet

We provide fully integrated services across every stage of drug product development.

This field is for validation purposes and should be left unchanged.